Skip to content

NFZPNLBIHPRPKW-RVPCSCLTSA-N

C37H43F6N3O7S — CID 155066312

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPAC[(2R,3S)-3-[4-[2-(4,4-dihydroxy-3-methylbutoxy)phenyl]-4-hydroxypiperidine-1-carbonyl]-2-propyl-3-[5-(trifluoromethyl)thiophen-3-yl]oxypiperidin-1-yl]-[4-(trifluoromethyl)-3-pyridinyl]methanone
SMILESCCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCC(O)(c2ccccc2OCCC(C)C(O)O)CC1
InChIInChI=1S/C37H43F6N3O7S/c1-3-7-29-35(53-24-20-30(54-22-24)37(41,42)43,12-6-16-46(29)31(47)25-21-44-15-10-26(25)36(38,39)40)33(50)45-17-13-34(51,14-18-45)27-8-4-5-9-28(27)52-19-11-23(2)32(48)49/h4-5,8-10,15,20-23,29,32,48-49,51H,3,6-7,11-14,16-19H2,1-2H3/t23?,29-,35+/m1/s1
InChIKeyNFZPNLBIHPRPKW-RVPCSCLTSA-N
MW787.82 g/mol
LogP6.63
Rot. Bonds12

About NFZPNLBIHPRPKW-RVPCSCLTSA-N

NFZPNLBIHPRPKW-RVPCSCLTSA-N (PubChem CID 155066312) has the molecular formula C37H43F6N3O7S and a molecular weight of 787.82 g/mol. Its IUPAC name is [(2R,3S)-3-[4-[2-(4,4-dihydroxy-3-methylbutoxy)phenyl]-4-hydroxypiperidine-1-carbonyl]-2-propyl-3-[5-(trifluoromethyl)thiophen-3-yl]oxypiperidin-1-yl]-[4-(trifluoromethyl)-3-pyridinyl]methanone.

Molecular Properties

Compound NameNFZPNLBIHPRPKW-RVPCSCLTSA-N
PubChem CID155066312
Molecular FormulaC37H43F6N3O7S
Molecular Weight787.82 g/mol
Exact Mass787.27
IUPAC Name[(2R,3S)-3-[4-[2-(4,4-dihydroxy-3-methylbutoxy)phenyl]-4-hydroxypiperidine-1-carbonyl]-2-propyl-3-[5-(trifluoromethyl)thiophen-3-yl]oxypiperidin-1-yl]-[4-(trifluoromethyl)-3-pyridinyl]methanone
SMILESCCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCC(O)(c2ccccc2OCCC(C)C(O)O)CC1
InChIInChI=1S/C37H43F6N3O7S/c1-3-7-29-35(53-24-20-30(54-22-24)37(41,42)43,12-6-16-46(29)31(47)25-21-44-15-10-26(25)36(38,39)40)33(50)45-17-13-34(51,14-18-45)27-8-4-5-9-28(27)52-19-11-23(2)32(48)49/h4-5,8-10,15,20-23,29,32,48-49,51H,3,6-7,11-14,16-19H2,1-2H3/t23?,29-,35+/m1/s1
InChIKeyNFZPNLBIHPRPKW-RVPCSCLTSA-N
XLogP6.63
TPSA132.66 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds12
Heavy Atoms54
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500787.82
LogP ≤ 56.63
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze NFZPNLBIHPRPKW-RVPCSCLTSA-N with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of NFZPNLBIHPRPKW-RVPCSCLTSA-N?
The IUPAC name of NFZPNLBIHPRPKW-RVPCSCLTSA-N (CID 155066312) is [(2R,3S)-3-[4-[2-(4,4-dihydroxy-3-methylbutoxy)phenyl]-4-hydroxypiperidine-1-carbonyl]-2-propyl-3-[5-(trifluoromethyl)thiophen-3-yl]oxypiperidin-1-yl]-[4-(trifluoromethyl)-3-pyridinyl]methanone.
What is the SMILES notation for NFZPNLBIHPRPKW-RVPCSCLTSA-N?
The canonical SMILES for NFZPNLBIHPRPKW-RVPCSCLTSA-N is CCC[C@H]1N(C(=O)c2cnccc2C(F)(F)F)CCC[C@@]1(Oc1csc(C(F)(F)F)c1)C(=O)N1CCC(O)(c2ccccc2OCCC(C)C(O)O)CC1.
What is the InChIKey of NFZPNLBIHPRPKW-RVPCSCLTSA-N?
The InChIKey is NFZPNLBIHPRPKW-RVPCSCLTSA-N. The full InChI is InChI=1S/C37H43F6N3O7S/c1-3-7-29-35(53-24-20-30(54-22-24)37(41,42)43,12-6-16-46(29)31(47)25-21-44-15-10-26(25)36(38,39)40)33(50)45-17-13-34(51,14-18-45)27-8-4-5-9-28(27)52-19-11-23(2)32(48)49/h4-5,8-10,15,20-23,29,32,48-49,51H,3,6-7,11-14,16-19H2,1-2H3/t23?,29-,35+/m1/s1.
What are the key properties of NFZPNLBIHPRPKW-RVPCSCLTSA-N?
NFZPNLBIHPRPKW-RVPCSCLTSA-N has a molecular weight of 787.82 g/mol, XLogP of 6.63, 12 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for NFZPNLBIHPRPKW-RVPCSCLTSA-N is sourced from PubChem (CID 155066312), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.